Keynote Lecturers
Characterization Methods by MS. Top-Down vs Bottom-Up vs Middle-Out, Shotgun Proteomics Problems, and Top-Down Protein Sequencing (TDS). What is the Meaning of all This?
February 7, 2011
Ira Krull
Chemistry, Northeastern University, Boston, Massachusetts, USA
“Dissolution testing in the oral drug absorption: shifting from an analytical to a formulation tool perspective“
February 7, 2011
Dionigio Franchi
Verona - Italy
Nanowire-based Sensor Arrays
February 7, 2011
Fernando Patolsky
School of Chemistry, Tel Aviv University
Archeological Analysis by Laser Mass Spectrometry
February 7, 2011
Mattanjah de Vries
University of California Santa Barbara, Santa Barbara, CA, USA
Mechanism of Enantioseparation on Macrocyclic Antibiotic Phases
February 7, 2011
Nelu Grinberg
Chemical Development, Boehringer Ingeleim Pharmaceuticals, Inc, Ridgefield, CT, USA
Elemental Analysis of Popular Fruits using Compton Suppression Neutron Activation Analysis
February 7, 2011
Sheldon Landsberger
Nuclear Engineering Teaching Lab, University of Texas, Austin, Texas, US
Phamacopoeial Monographs: Development, modernization and updates
February 8, 2011
Karen A. Russo
USP, USA
Characterization of Glycoprotein Complexes with Hydrophobic Materials and Nanomaterials
February 8, 2011
Michael Gozin
School of Chemistry, Tel Aviv University, Tel Aviv, Israel
Schlieren Imaging: Revealing the Dark Secrets of Gas Flow
February 8, 2011
Eyal Elish
Nuclear Research Center Negev (NRCN), Beer-Sheva, Israel
Biomolecular Nanostructure-Modified Electrodes For Biosensing
February 8, 2011
Ran Tel-Vered
Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem
5975-SMB – A New Supersonic GC-MS with Advanced Capabilities
February 8, 2011
Aviv Amirav
School of Chemistry,
Tel Aviv University, Tel Aviv, Israel
Erythromycin Degradation Products in Various Aquatic Environments-Identification and Detection
February 8, 2011
Igal Gozlan
Hydrochemistry Laboratory, Tel Aviv University, Israel
Current Concerns, Requirements, Strategies & Techniques in Quality Control & Validation of Biological Based Therapies
February 8, 2011
Charles Christy
Biotechnology Services, Covance, Harrogate UK, Harrogate, UK
|
